BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 20, 2019
View Archived Issues
Recruitment ongoing in Immunocore's first-in-human study of IMC-C103C
Read More
Boston Pharmaceuticals begins phase IIa study of BOS-589 in IBS-D
Read More
Norovirus' bright side
Read More
Beactica receives grant to advance research on preclinical candidate BEA-17 for glioblastoma
Read More
BeiGene, SpringWorks form MapKure to develop next-generation RAF kinase inhibitor BGB-3245
Read More
Phase I/II study of nivolumab plus radical surgery in microsatellite stable LARC
Read More
Muscle CB1R regulates whole-body metabolism and physical performance, novel mouse model shows
Read More
Cellular lung map gives asthma, other insights
Read More
Recruitment ongoing in phase I study of VSV-IFNb-TYRP1 for the treatment of melanoma
Read More
Arch Biopartners initiates phase I study of Metablok
Read More
Positive early safety and efficacy results of phase I/II study of nomacopan in AKC
Read More
Updated positive results for phase Ib study of resiniferatoxin in knee osteoarthritis pain
Read More
Apatinib monotherapy shows promising efficacy and manageable toxicities in mCRC
Read More
Durvalumab in combination with R-CHOP shows promising response rates in high-risk DLBCL
Read More
Abatacept misses primary endpoint in Sjogren's syndrome in phase III study
Read More
Step Pharma discovers new CTP synthase 1 inhibitors
Read More
5-HT7 antagonists patented by KAIST, KIST
Read More
Servier, Vernalis disclose ubiquitin carboxyl-terminal hydrolase 7 inhibitors
Read More
Disulfiram and copper with concurrent RT and temozolomide for glioblastoma: phase I/II trial
Read More
Janssen presents compound for respiratory syncytial virus infections
Read More
New Janus kinase inhibitors synthesized at Korea Pharma
Read More
Loss of NFASC NF186 isoform tied to hereditary ataxia
Read More
New phase I study evaluates TBX-3400 in stage III/IV melanoma resistant or refractory to immune CPIs
Read More
GSK initiates phase III trials of GSK-3196165 in moderate to severely active rheumatoid arthritis
Read More
DiaMedica reports phase Ib interim data on DM-199 in chronic kidney disease
Read More
PCYT2 gene mutations seen to cause neurological disorder
Read More